Subscribe
Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

JAMA Editor’s Summary

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the issue.
September 14, 2021

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

Editor’s Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the September 14, 2021 issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Y’all Means All Communities are powered by people—and the variety of lives, jobs, schedules, and skills keep cities buzzing. Providing care means healthcare has to show up for "y’all" no matter the gender identity, work schedule, or preferred language.